A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
N/A
Synonyms :
4-aminohippuric acid, Aminohippurate, aminohippuric acid, N-(p-Aminobenzoyl)glycine, p-aminohippurate, p-aminohippuric acid, PAHA, para-aminohippurate, para-aminohippuric acid, paraaminohippuric acid
Class :
Diagnostic agents/ Transporter substrate
Dosage forms& StrengthsÂ
Injectable solution (IV)Â
20%Â
Safety and efficacy are not seen in pediatricsÂ
Refer to the adult dosingÂ
When aminohippuric acid is used together with ouabain, this leads to reduction in aminohippuric acid excretion
aminohippuric acid has the potential to increase the serum concentration of procainamide
when co-administered with aminohippuric acid, the excretion of quinapril may be reduced
the combination of quinidine may result in a decreased excretion of aminohippuric acid
combining aminohippuric acid may lead to a decreased excretion of cholecystokinin
the combination of probenecid may decrease the excretion of aminohippuric acid
aminohippuric acid has the potential to reduce the excretion of raloxifene
combining ranitidine may lead to a decreased excretion of aminohippuric acid
the excretion of relebactam can be diminished when combined with aminohippuric acid
aminohippuric acid may reduce the excretion of repaglinide
aminohippuric acid has the potential to increase the serum concentration of reserpine
aminohippuric acid may result in a decreased excretion rate of revefenacin, potentially causing elevated serum levels
may have a decrease in excretion when combined with aminohippuric acid
Actions and spectrum:Â
Actions:Â
The renal glomeruli filter aminohippurate which is then secreted into the urine by the proximal tubules. It is possible to determine the effective renal plasma flow and to measure the amount of the drug in the urine by which it can be known to estimate the functional capacity of kidney.Â
Adverse reactionsÂ
AnaphylaxisÂ
TinglingÂ
AngioedemaÂ
vasomotor disturbancesÂ
flushingÂ
UrticariaÂ
CrampsÂ
NauseaÂ
VomitingÂ
Black box warningÂ
During administration of aminohippuric acid, level of electrolytes must be monitored thoroughlyÂ
Contraindications/CautionÂ
ContraindicationsÂ
HypersensitivityÂ
CautionÂ
Renal impairmentÂ
Hepatic impairmentÂ
PregnancyÂ
LactationÂ
Low cardiac reserve patientsÂ
Allergy to latexÂ
Pregnancy & breastfeeding:Â
Pregnancy consideration:Â
Safety and efficacy data about the use of aminohippuric acid in pregnancy is not establishedÂ
Breastfeeding warnings:Â
Data about the excretion of the drug into human milk is not known Â
Pregnancy category:Â
Pharmacology:Â
Aminohippurate is a glycine amide of p-aminobenzoic acid. It is a derivative injection of hippuric acid used to measure renal functioning.Â
Pharmacodynamics:Â
P-Aminohippuric acid (PAH, PAHA) is the glycine amide of p-aminobenzoic acid. By the glomeruli, it is filtered and secreted actively by the proximal tubules. At lower plasma concentrations (1.0 to 2.0 mg/100 mL), ninety percent of aminohippurate on an average is cleared from the renal blood stream of the kidneys in one circulation. It is very well-suited to the estimation of ERPF due to its high clearance, a relatively nontoxic state achieved only at the over-recommended dose and the analytic determination is precise and simple. This drug is also used for the purpose of secretion ability measurement of the renal tubular cells (transport maximum maximum, TmPAH) as well. This is done through the build-up of the plasma concentration to the levels (40 to 60 mg/100 mL) necessary to overload the tubular cells with aminohippurate. Inulin clearance is typically performed during TmPAH assessments since the knowledge of the glomerular filtration rate (GFR) must be a prerequisite for secretory Tm calculations.Â
Pharmacokinetics:Â
Elimination and excretion:Â
The drug is likely to be excreted via urine. Renal clearance at low concentrations of plasma in a single circulation is observed to be 90%.Â
Half-life:
24 minutesÂ
Administration:Â
The drug should be administered as an intravenous injection directly into the blood stream.Â
It should be given by the specialist and carried out under the guidance of licensed medical practitioners.Â
Patient information leafletÂ
Generic Name: aminohippuric acidÂ
Pronounced: uh-MEE-noh-HIP-yur-ik AS-idÂ
Why do we use aminohippuric acid?Â
It is the most acceptable procedure to control the blood flow in the kidney. This drug assists in calculating ERPF, the plasma flow in the kidney glomeruli that removes the wastes from the blood stream by filtration so that the functional capability of kidneys can be evaluated.Â